tiprankstipranks
Trending News
More News >
Oncolys BioPharma, Inc. (JP:4588)
:4588
Japanese Market

Oncolys BioPharma, Inc. (4588) Revenue

Compare
0 Followers

Oncolys BioPharma, Inc. Revenue

Oncolys BioPharma, Inc. had a revenue of 0.00 in the quarter ending Mar 31, 2024, with ―. This bring the company's revenue in the last twelve months to 28.04M, Increased -55.52%. In the fiscal year ending Dec 31, 2023, Oncolys BioPharma, Inc. had annual revenue of 63.04M with -93.54% growth.
Revenue (ttm)
28.04M
Revenue Growth
-50.21%
P/S Ratio
219.84
Revenue/Employee
¥1,575,950
Employees
40
Market Cap
¥13.86B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 202363.04M-913.14M-93.54%
Dec 31, 2022976.18M333.69M+51.94%
Dec 31, 2021642.49M328.31M+104.50%
Dec 31, 2020314.18M-989.66M-75.90%
Dec 31, 20191.30B1.14B+673.57%
Dec 31, 2018168.55M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis